Table of Contents

1 Study Coverage

• 1.1 Midostaurin Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Midostaurin Market Size Growth Rate by Product
  • 1.4.2 AML
  • 1.4.3 MDS
  • 1.4.4 Other
• 1.5 Market by End User
  • 1.5.1 Global Midostaurin Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Pharmacy
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Midostaurin Market Size
  • 2.1.1 Global Midostaurin Revenue 2014-2025
  • 2.1.2 Global Midostaurin Sales 2014-2025
• 2.2 Midostaurin Growth Rate by Regions
  • 2.2.1 Global Midostaurin Sales by Regions
  • 2.2.2 Global Midostaurin Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Midostaurin Sales by Manufacturers
  • 3.1.1 Midostaurin Sales by Manufacturers
  • 3.1.2 Midostaurin Sales Market Share by Manufacturers
  • 3.1.3 Global Midostaurin Market Concentration Ratio (CR5 and HHI)
• 3.2 Midostaurin Revenue by Manufacturers
  • 3.2.1 Midostaurin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Midostaurin Revenue Share by Manufacturers (2014-2019)
• 3.3 Midostaurin Price by Manufacturers
• 3.4 Midostaurin Manufacturing Base Distribution, Product Types
  • 3.4.1 Midostaurin Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Midostaurin Product Type
  • 3.4.3 Date of International Manufacturers Enter into Midostaurin Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Midostaurin Sales by Product
• 4.2 Global Midostaurin Revenue by Product
• 4.3 Midostaurin Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Midostaurin Breakdown Data by End User

6 North America

• 6.1 North America Midostaurin by Countries
  • 6.1.1 North America Midostaurin Sales by Countries
  • 6.1.2 North America Midostaurin Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Midostaurin by Product
• 6.3 North America Midostaurin by End User

7 Europe

• 7.1 Europe Midostaurin by Countries
  • 7.1.1 Europe Midostaurin Sales by Countries
  • 7.1.2 Europe Midostaurin Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Midostaurin by Product
• 7.3 Europe Midostaurin by End User

8 Asia Pacific

• 8.1 Asia Pacific Midostaurin by Countries
  • 8.1.1 Asia Pacific Midostaurin Sales by Countries
  • 8.1.2 Asia Pacific Midostaurin Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Midostaurin by Product
• 8.3 Asia Pacific Midostaurin by End User

9 Central & South America

• 9.1 Central & South America Midostaurin by Countries
  • 9.1.1 Central & South America Midostaurin Sales by Countries
  • 9.1.2 Central & South America Midostaurin Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Midostaurin by Product
• 9.3 Central & South America Midostaurin by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Midostaurin by Countries
  • 10.1.1 Middle East and Africa Midostaurin Sales by Countries
  • 10.1.2 Middle East and Africa Midostaurin Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Midostaurin by Product
• 10.3 Middle East and Africa Midostaurin by End User

11 Company Profiles

• 11.1 Novartis
  • 11.1.1 Novartis Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Novartis Midostaurin Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Novartis Midostaurin Products Offered
  • 11.1.5 Novartis Recent Development

12 Future Forecast

• 12.1 Midostaurin Market Forecast by Regions
  • 12.1.1 Global Midostaurin Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Midostaurin Revenue Forecast by Regions 2019-2025
• 12.2 Midostaurin Market Forecast by Product
  • 12.2.1 Global Midostaurin Sales Forecast by Product 2019-2025
  • 12.2.2 Global Midostaurin Revenue Forecast by Product 2019-2025
• 12.3 Midostaurin Market Forecast by End User
• 12.4 North America Midostaurin Forecast
• 12.5 Europe Midostaurin Forecast
• 12.6 Asia Pacific Midostaurin Forecast
• 12.7 Central & South America Midostaurin Forecast
• 12.8 Middle East and Africa Midostaurin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Midostaurin Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis.
The global Midostaurin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Midostaurin market based on company, product type, end user and key regions.

This report studies the global market size of Midostaurin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Midostaurin in these regions.
This research report categorizes the global Midostaurin market by top players/brands, region, type and end user. This report also studies the global Midostaurin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis

Market size by Product
AML
MDS
Other
Market size by End User
Hospital
Pharmacy

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Midostaurin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Midostaurin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Midostaurin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Midostaurin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Midostaurin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Midostaurin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.